Transplantable bioartificial pancreas devices: Current status and future prospects.
Langenbecks Arch. Surg. 400, 531-540 (2015)
Islet transplantation has become a valuable therapy for patients with diabetes mellitus type 1.However, only selected patients with exhausted insulin therapy characterized by instable metabolic control and repeated severe hypoglycemia are transplant candidates. This strict indication is mainly due to the requirement for lifelong immunosuppression and the critical shortage for donor organs. Therefore, numerous research activities address these issues in order to provide beta cell replacement therapy to a broader cohort of patients with diabetes. The encapsulation of pancreatic islets within mainly alginate-based macro- or microcapsules withvarious physical configurations may allow protecting the islet graft without the need for immunosuppressive agents and moreover expanding the donor pool to animal tissue and novel insulin-producing cells. Despite major advances in encapsulation technology, a significant translation into clinical application is not evident. There are still issues that need to be resolved associated with graft oxygenation, immunprotection, inflammatory response, material biocompatibility, and transplantation site to list some of them. The recent advances in xenotransplantation and particularly in the field of stem cell-derived beta cells have generated a renewed scientific interest in encapsulation. This review aims to provide an overview on current encapsulation technologies as a treatment modality in cell replacement therapy for type 1 diabetes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Diabetes ; Transplantation ; Encapsulation; Mediated Inflammatory Reaction; Biohybrid Artificial Pancreas; Complement Receptor 1; Long-term Function; Islet Transplantation; Diabetes-mellitus; Diffusion-chamber; In-vivo; Interfacial Photopolymerization; Microencapsulated Islets
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2015
Prepublished im Jahr
HGF-Berichtsjahr
2015
ISSN (print) / ISBN
1435-2443
e-ISSN
1435-2451
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 400,
Heft: 5,
Seiten: 531-540
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Springer
Verlagsort
Berlin ; Heidelberg [u.a.]
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Pancreatic Islet Research (IPI)
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502600-001
Förderungen
Copyright
Erfassungsdatum
2015-07-31